Global Newborn Screening Market - Industry Analysis and Market Forecast 2017 - 2022

  • ID: 4387307
  • Report
  • Region: Global
  • 193 pages
  • Mordor Intelligence
1 of 3
The global newborn screening market is expected to reach USD XX million by 2021, growing at a CAGR of XX%. Newborn screening is performed to screen infants after birth for the detection of any health conditions or diseases that can be fatal but are not detected during birth. The newborn screening tests are basically an evaluation of metabolites and blood samples. These tests vary according to different country jurisdictions. In many areas, newborn screening tests include screening for hearing loss and congenital heart disease. The major diseases screened for are sickle cell disease, cystic fibrosis, newborn hearing loss, congenital hypothyroidism, phenyl ketone urea and congenital heart disease.

Global Newborn Screening Market- Market Dynamics

The report details several driving and restraining factors for the global newborn screening market. Some of them are listed below.


Presence of federal bodies for organizing awareness programs

Increasing awareness in developed countries

Technological advancements in healthcare

Increasing array of newborn diseases

More physicians advising newborn screening tests


Lack of awareness in developing countries

Lack of trained professionals

Socio-economic barriers in developing countries

The global newborn screening market has been segmented based on technology, product, test type, and geography. The segmentation based on technology has been subdivided into tandem mass spectrometry, DNA-based assay, enzyme, and immunoassays, electrophoresis, hearing screening technology, and pulse oximetry technology. The segmentation based on product is sub-divided into newborn disorder screening instruments, hearing screening devices and accessories, pulse oximetry, and reagents and assay kits. The segmentation based on test type has been sub-divided into critical congenital heart disease test, hearing screening test, and dry blood spot test.

Amongst technologies being used, tandem mass spectrometry is expected to have the highest growth rate during the forecast period. The dry blood spot test has the largest market share in the segment by test type.

Based on geography, the global newborn screening test market has been segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. The segmentation on North America discusses different market trends, and market size of newborn screening tests in the USA, Canada, and Mexico. The Europe segment has been further subdivided into UK, France, Italy, Germany, Benelux, Scandinavia, Spain and Portugal. The segmentation on Asia-Pacific has been subdivided into China, Japan, India, South Korea, Australia, and New Zealand. The Middle-east & North Africa segment includes GCC, Egypt, and others. The South America region includes Brazil, Argentina, Colombia and others.

This Report Offers:

Market definition for the global newborn screening market along with identification of key drivers and restraints for the market.

Market analysis for the newborn screening test market, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect the newborn screening test market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Study deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast period years
1.6 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry trends
5.1 Current Market Scenario
5.2 Newborn Screening test Applications
5.3 Technology Overview
5.4 New Developments
5.5 Industry Value chain analysis
5.6 Product Lifecycle analysis
5.7 Product Benchmarking
5.8 Investment Analysis
5.9 Porter's Five Forces
5.9.1 Bargaining Power of Suppliers
5.9.2 Bargaining Power of Consumers
5.9.3 Threat to new entrants
5.9.4 Threat to substitute products and services
5.9.5 Competitive Rivalry within the industry
6. Drivers, Restraints, Opportunities, and challenges Analysis
6.1 Market Drivers
6.1.1 Presence of federal bodies for organizing awareness programs
6.1.2 Increasing awareness in Developed countries
6.1.3 Technological Advancements
6.1.4 Government support
6.1.5 Increasing array of newborn diseases
6.2 Market Restraints
6.2.1 Lack of awareness in developing countries
6.2.2 Lack of trained professional
6.2.3 Socio- economic barriers in developing nations Market Opportunities Government Initiatives Market Challenges
6.3 Lack of advanced healthcare facilities in developing nations
6.4 Lack of awareness amongst a large population globally
7. Global Newborn Screening Market segmentation
7.1 Introduction
7.2 Segmentation by Technology
7.2.1 Tandem Mass Spectrometry
7.2.2 DNA based assay
7.2.3 Enzymes and Immunoassays
7.2.4 Electrophoresis
7.2.5 Hearing Screen Technology
7.2.6 Pulse Oximetry Technology
7.3 Segmentation by Product
7.3.1 Newborn disorder Screening Instruments
7.3.2 Hearing screening devices, and Accessories
7.3.3 Pulse Oximetry
7.3.4 Reagents and assay kits
7.4 Segmentation by test type
7.4.1 Critical Congenital Heart Disease (CCHD) Test
7.4.2 Hearing Screening Test
7.4.3 Dry blood Spot Test
8. Market segmentation by Geography - North America
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.2 Europe
8.2.1 Introduction
8.2.2 Germany
8.2.3 United Kingdom
8.2.4 France
8.2.5 Italy
8.2.6 Spain
8.2.7 Scandinavia
8.2.9 Rest of Europe
8.3 Asia-Pacific (APAC)
8.3.1 Introduction
8.3.2 China
8.3.3 Japan
8.3.4 India
8.3.5 Australia and New Zealand
8.3.6 South Korea
8.3.7 Rest of Asia-Pacific
8.4 Middle East and North Africa
8.4.1 Introduction
8.4.2 GCC
8.4.3 Egypt
8.4.4 Rest of Middle East & Africa
8.5 South America
8.5.1 Introduction
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Rest of Latin America
9. Competitive Landscape
9.1 Merger and acquisition analysis
9.2 New Product Launches
9.3 Agreements, Collaborations, and Partnerships
10. Key Vendor Analysis
10.1 Agilent Technologies
10.2 AB Sciex LLC
10.3 Covidien PLC
10.4 PerkinElmer Inc.
10.5 Trivitron Healthcare
10.6 Bio-Rad Laboratories
10.7 Masimo Corporation
10.8 Natus Medical
10.9 Waters Corporation
10.10 GE Healthcare
11. Analyst outlook for Investment opportunities
12. Future Outlook of the market
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown